{
    "code": "60001088",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001088",
    "time": "2019-06-21 03:08:38",
    "許可證字號": "衛部菌疫輸字第001088號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/10\/11",
    "發證日期": "107\/10\/11",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000108801",
    "中文品名": "抑癌寧注射劑",
    "英文品名": "IMFINZI Injection 50 mg\/ml",
    "適應症": "IMFINZI適用於治療患有局部晚期、無法手術切除的非小細胞肺癌，且接受放射治療合併含鉑化療後病情未惡化的病人。",
    "劑型": "270注射劑",
    "包裝": "2.4毫升(vial)玻璃小瓶裝 100支以下盒裝 10毫升(vial)玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "Durvalumab",
    "主製造廠": {
        "申請商名稱": "1434901100  臺灣阿斯特捷利康股份有限公司",
        "申請商地址": "台北市大安區敦化南路二段207號21樓",
        "主製造廠": "",
        "製造廠名稱": "FDE0559000  VETTER PHARMA-FERTIGUNG GMBH &amp; CO KG"
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FSE0032000  ASTRAZENECA AB",
            "製造廠廠址": "S-151 85 SODERTALJE SWEDEN",
            "製造廠公司地址": "",
            "製造廠國別": "SWEDEN",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FUS0980100  ASTRAZENECA PHARMACEUTICALS LP",
            "製造廠廠址": "FREDERICK MANUFACTURING CENTER, 633 RESEARCH COURT, MD 21703, FREDERICK, US",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "101300700",
            "成分名稱": "Durvalumab",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG\/ML"
        }
    ],
    "仿單外盒": [
        {
            "title": "IMFINZI中文仿單-PS15781-108-04-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=002&Type=9"
        },
        {
            "title": "4-1. Imfinzi 中文仿單-107-10-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=001&Type=9"
        },
        {
            "title": "IMFINZI 500mg 1x10ml-標籤-PS13177-108-04-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=007&Type=8"
        },
        {
            "title": "IMFINZI 500mg 1x10ml-外盒-PS15783-108-04-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=006&Type=8"
        },
        {
            "title": "IMFINZI 120mg 1x2.4ml-標籤-PS13176-108-04-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=005&Type=8"
        },
        {
            "title": "IMFINZI 120mg 1x2.4ml-外盒-PS15782-108-04-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=004&Type=8"
        },
        {
            "title": "4-4. Imfinzi 500mg-外盒-107-10-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=003&Type=8"
        },
        {
            "title": "4-3. Imfinzi 120mg-標籤-107-10-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=002&Type=8"
        },
        {
            "title": "4-2. Imfinzi 120mg-外盒-107-10-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=001&Type=8"
        }
    ]
}